521 related articles for article (PubMed ID: 16875606)
21. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
[TBL] [Abstract][Full Text] [Related]
22. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834
[TBL] [Abstract][Full Text] [Related]
23. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma.
Ho DW; Yang ZF; Wong BY; Kwong DL; Sham JS; Wei WI; Yuen AP
Cancer; 2006 Jul; 107(1):99-107. PubMed ID: 16708360
[TBL] [Abstract][Full Text] [Related]
24. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
Solassol J; Marin P; Maudelonde T; Mangé A
Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
[TBL] [Abstract][Full Text] [Related]
25. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
26. [Tree analysis pattern of mass spectral urine profiles in differential diagnosis of bladder transitional cell carcinoma].
Wu DL; Zhang YF; Guan M; Liu WW; Xu YM; Jin SB; Zhang J; Jin CR; Lü Y
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):274-7. PubMed ID: 17760254
[TBL] [Abstract][Full Text] [Related]
27. [Proteomics and breast cancer].
Mathelin C; Tomasetto C; Cromer A; Rio MC
Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
29. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
30. [Preliminary study of serum proteome biomarkers of hypopharyngeal squamous cell carcinoma].
Cheng L; Zhou L; Tao L; Xiang CQ; Jia XD; Lu Y; Liao P
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1484-8. PubMed ID: 16842702
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
Liu DH; Zhang LM; Feng WY
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
[No Abstract] [Full Text] [Related]
32. Use of serological proteomic methods to find biomarkers associated with breast cancer.
Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R
Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611
[TBL] [Abstract][Full Text] [Related]
33. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
34. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection.
Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z
Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511
[TBL] [Abstract][Full Text] [Related]
35. [Application of serum protein fingerprint model and support vector machine in diagnosis of thyroid cancer].
Wang JX; Wang L; Fan YZ; Liu QL; Zhang J; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):979-82. PubMed ID: 16759540
[TBL] [Abstract][Full Text] [Related]
36. Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry.
Zhou M; Prieto DA; Lucas DA; Chan KC; Issaq HJ; Veenstra TD; Conrads TP
J Proteome Res; 2006 Sep; 5(9):2207-16. PubMed ID: 16944932
[TBL] [Abstract][Full Text] [Related]
37. Serum biomarkers for detection of breast cancers: A prospective study.
Mathelin C; Cromer A; Wendling C; Tomasetto C; Rio MC
Breast Cancer Res Treat; 2006 Mar; 96(1):83-90. PubMed ID: 16322896
[TBL] [Abstract][Full Text] [Related]
38. [Establishment of a diagnostic model of serum protein fingerprint pattern for esophageal cancer screening in high incidence area and its clinical value].
Wang SJ; Zhang LW; Yu WF; Yu JK; Zheng S; Li YS; Er LM; Wen DG; Gao JH
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):441-3. PubMed ID: 17974279
[TBL] [Abstract][Full Text] [Related]
39. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
[TBL] [Abstract][Full Text] [Related]
40. Serum protein profile analysis in patients with head and neck squamous cell carcinoma.
Gourin CG; Xia ZS; Han Y; French AM; O'Rourke AK; Terris DJ; Adam BL
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):390-7. PubMed ID: 16618908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
